Tag Archives: pharmaceutical

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

“Circular 1 of 2012”- India’s Consolidated FDI Policy Document

The consolidated FDI policy document is a single reference point for investors and regulators. The first such consolidation was released in March, 2010 after which it has been updated every six months.  This ‘Circular 1 of 2012’-is the fifth edition … Continue reading

Posted in Notifications/Publications/Circulars | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

No confusion between PLAX and CLAX

Intellectual Property Appellate Board (India) ruled that Colgate-Palmolive’s trademark PLAX and Cadila Pharmaceuticals Limited trademark CLAX are not similar as the goods for which the respective trademarks are used are different even though both the trademarks fall in Class 5. … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , | 2 Comments